https://ny-newswire.com/wp-content/uploads/2022/11/relief-logo.jpeg
440
386
George
George
https://ny-newswire.com/wp-content/uploads/2021/09/George-96x96.jpg
RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTD) (“Relief”), a Swiss, commercial-stage biopharmaceutical company identifying, developing, and commercializing novel, patent protected products in selected specialty, rare and ultra-rare disease areas on a global basis, today announced promising six-month stability…